Jay Goldberg of the Consumer Choice Center argues the $50 copay only covers some Medicare patients, and points to PBM reform and competition instead.
Recap by typeshit. Full story at Boston Herald.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
South Korea's Ministry of Food and Drug Safety says it flagged hundreds of listings illegally selling or promoting weight-loss drugs.
Forbes covers a World Health Organization warning against GLP-1 weight loss drugs for kids and explains the reasoning behind it.
Loading…